This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Vaccinia Virus 14 kDa Fusion Protein, C-His
Product Overview
BioVenic's Recombinant Vaccinia Virus 14 kDa Fusion Protein, C-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 14.5 kDa. The purity is>95% (SDS-PAGE).
Specifications
Target Information
Vaccinia virus 14 kDa fusion protein is a critical component in the virus's life cycle, facilitating virus entry into host cells through endocytosis and mediating cell fusion at acid pH. This protein, encoded by the A27L gene, is involved in virus-to-cell and cell-to-cell fusions, playing a significant role in the dissemination of the virus within the host. It also forms a stable complex with the 21-kilodalton protein encoded by the A17L gene, which is crucial for its function.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.